Skip to main content
. 2022 Dec 11;14(24):6097. doi: 10.3390/cancers14246097

Table 2.

ROMs for non-A113_spice site and A113_spilce site mutations.

Type of EIF1AX Mutation ROM (%) ROM or NIFTPs/WDT-UMPs (%) ROM for Nodules with ≥1 Additional Molecular Alteration (%) ROM for Nodules with Concurrent RAS (%) ROM for Nodules with TP53 (%)
All 47.6 61.9 72.7 100 66.7
non-A113_splice site 36 56 100 0
A113_splice site 70.6 70.6 100 100 100